Regularly taking glucosamine supplements is linked to a ‘significantly lower risk’ of cardiovascular disease (CVD), a new study has found.
Related Article: ‘Precautionary’ recall of breast cancer medication batch
Study participants without cardiovascular disease took regular glucosamine supplements between 2006 and 2016, resulting in fewer CVD events, CVD-related deaths, coronary heart disease and stroke incidences.
Related Article: Customer complaint prompts recall of Omeprazole oral solution batch
The study of nearly half a million (466,039) adults was carried out by the health resource UK Biobank and published in the British Medical Journal on Tuesday (14 May).
Glucosamine is usually taken by patients to help ease joint problems, although the supplement’s effectiveness for this ‘continues to be debated’, the study said.
Related Article: Pharmacists urged to step into shared care role for ADHD as service gaps grow
Habitual use of the supplements to relieve joint pain could therefore also relate to lower risk of CVD events, the study’s authors concluded, although further clinical trials are needed to test this theory.
Keep your clinical knowledge up to date with The Pharmacist
Extend your learning and record your learning outcomes
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.